Related references
Note: Only part of the references are listed.Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery A Randomized Trial
Vance G. Fowler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Genomic responses in mouse models poorly mimic human inflammatory diseases
Junhee Seok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
High Prevalence of Isolates with Reduced Glycopeptide Susceptibility in Persistent or Recurrent Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus
Ilker Uckay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
A Recombinant Clumping Factor A-Containing Vaccine Induces Functional Antibodies to Staphylococcus aureus That Are Not Observed after Natural Exposure
Julio Hawkins et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Progress Toward a Staphylococcus aureus Vaccine
Robert S. Daum et al.
CLINICAL INFECTIOUS DISEASES (2012)
Challenges for a Universal Staphylococcus aureus Vaccine
Richard A. Proctor
CLINICAL INFECTIOUS DISEASES (2012)
Host Response Signature to Staphylococcus aureus Alpha-Hemolysin Implicates Pulmonary Th17 Response
Karen M. Frank et al.
INFECTION AND IMMUNITY (2012)
Abscess Formation and Alpha-Hemolysin Induced Toxicity in a Mouse Model of Staphylococcus aureus Peritoneal Infection
Sabine Rauch et al.
INFECTION AND IMMUNITY (2012)
Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors
Annaliesa S. Anderson et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Will we ever see the approval of a Staphylococcus aureus vaccine?
Joseph M. Patti
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Identifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responses
Hwan Keun Kim et al.
FASEB JOURNAL (2011)
Scenery of Staphylococcus implant infections in orthopedics
Lucio Montanaro et al.
FUTURE MICROBIOLOGY (2011)
Challenges for the evaluation of Staphylococcus aureus protein based vaccines Monitoring antigenic diversity
Ellen Murphy et al.
HUMAN VACCINES (2011)
Immunotherapeutic approaches against Staphylococcus aureus
Nelianne J. Verkaik et al.
IMMUNOTHERAPY (2011)
Resolution of Staphylococcus aureus Biofilm Infection Using Vaccination and Antibiotic Treatment
Rebecca A. Brady et al.
INFECTION AND IMMUNITY (2011)
Staphylococcal Alpha-Toxin Is a Strong Inducer of Interleukin-17 in Humans
Margarete Niebuhr et al.
INFECTION AND IMMUNITY (2011)
A guide to defining and implementing protocols for the welfare assessment of laboratory animals: eleventh report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement
P. Hawkins et al.
LABORATORY ANIMALS (2011)
Novel targeted immunotherapy approaches for staphylococcal infection
Michael Otto
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Staphylococcus aureus adaptation to the host and persistence: role of loss of capsular polysaccharide expression
Lorena Tuchscherr et al.
FUTURE MICROBIOLOGY (2010)
Role of Interleukin-17A in Cell-Mediated Protection against Staphylococcus aureus Infection in Mice Immunized with the Fibrinogen-Binding Domain of Clumping Factor A
Kouji Narita et al.
INFECTION AND IMMUNITY (2010)
Identification of the active component that induces vancomycin resistance in MRSA
Shinsuke Ikeda et al.
JOURNAL OF ANTIBIOTICS (2010)
Staphylococcus aureus Small-Colony Variants Are Adapted Phenotypes for Intracellular Persistence
Lorena Tuchscherr et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Targeting of Alpha-Hemolysin by Active or Passive Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model
Adam D. Kennedy et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Community-associated meticillin-resistant Staphylococcus aureus
Frank R. DeLeo et al.
LANCET (2010)
NOD2 contributes to cutaneous defense against Staphylococcus aureus through α-toxin-dependent innate immune activation
Petr Hruz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Incidence and Characteristics of Vancomycin Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus at Hershey Medical Center
Klaudia Kosowska-Shick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Antibodies to Capsular Polysaccharide and Clumping Factor A Prevent Mastitis and the Emergence of Unencapsulated and Small-Colony Variants of Staphylococcus aureus in Mice
Lorena P. N. Tuchscherr et al.
INFECTION AND IMMUNITY (2008)
Vaccination and passive immunisation against Staphylococcus aureus
Adam C. Schaffer et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Vaccine protection against Staphylococcus aureus pneumonia
Juliane Bubeck Wardenburg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Fibrinogen Binding Sites P336 and Y338 of Clumping Factor A Are Crucial for Staphylococcus aureus Virulence
Elisabet Josefsson et al.
PLOS ONE (2008)
Invasive methicillin-resistant Staphylococcus aureus infections in the United States
R. Monina Klevens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Clinical trial of safety and efficacy of IHN-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants
Mitchell Dejonge et al.
JOURNAL OF PEDIATRICS (2007)
Translation of research evidence from animals to humans
Daniel G. Hackam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Use of a conjugate polysaccharide vaccine in the prevention of invasive staphylococcal disease: Is an additional vaccine needed or possible?
HR Shinefield
VACCINE (2006)
Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections
RA Proctor et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Community-acquired methicillin-resistant Staphylococcus aureus:: current perspectives
MFQ Kluytmans-VandenBergh et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Variation of polymorphic region C of the protein A gene during persistent airway infection of cystic fibrosis patients reflects two independent mechanisms of genetic change in Staphylococcus aureus
BC Kahl et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX®) in hemodialysis patients
A Fattom et al.
VACCINE (2004)
Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis
J Vernachio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.
H Shinefield et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant
E Josefsson et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Treating chronic diffuse sclerosing osteomyelitis of the mandible with saucerization and autogenous bone grafting
A Ogawa et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS (2001)
Share Paper
